This measure identifies the percentage of patients with chronic Hepatitis C (HCV) who began HCV antiviral therapy during the measurement year and had HCV Viral Load testing 6 months prior to initiation of antiviral therapy.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients in the denominator who had an HCV Viral Load test 6 months prior to the initiation of antiviral therapy.
-
1.15 Denominator
Our denominator is anyone with Hepatitis C diagnosed anytime in the past, based on historical claims on file, who have a new start of peginterferon in the last year, excluding people with documentation of a medical reason(s) for not performing quantitative HCV RNA testing within 6 months prior to initiation of treatment (CPT Category II code 3218F-1P).
-
Exclusions
Exclude anyone with a code which states the patient has a medical reason for not having the test done.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Infectious Disease Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
Copyright © 2008 – Resolution Health, Inc. All rights reserved. The material submitted is confidential and proprietary. No use of this material is permitted other than in accordance with the Agreement with Measure Stewards between National Quality Forum and Resolution Health, Inc.
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)
-